BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Ginsenoside Ra2 | Ginsenoside Ra2 is a known ginsenoside isolated from the root of Panax ginseng. Previous phytochemical studies on P. ginseng led to the isolation of ginsenosides (triterpenoid saponin glycosides), polyacetylenes, sesquiterpenoids, flavonoids, and polysaccharides. Group: Pharmaceutical. CAS No. 83459-42-1. Pack Sizes: 20 mg. Product ID: B0005-479870. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Ginsenoside Ra3 | Ginsenoside Ra3 is isolated from the root of Panax ginseng. Protopanaxadiol- and protopanaxatriol-type ginsenosides are the major biologically active components of P. ginseng that contribute to its diverse pharmacological effects on the central nervous system, cardiovascular system, endocrine secretion, immune-modulation, metabolism, stress, aging, and cancer. Group: Pharmaceutical. CAS No. 90985-77-6. Pack Sizes: 5 mg. Product ID: B0005-479872. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rb1 | A major bioactive component of panax ginseng that promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. It has been reported to display immunostimulatory and anticancer effects. It has anti-aging effect, can be used in health products. Uses: Anti-oxidative damage,immunostimulatory,anticancer. Group: Pharmaceutical. CAS No. 41753-43-9. Pack Sizes: 100 mg. Product ID: NP6991. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rb2 | Ginsenoside Rb2 is a 20(S)-protopanaxadiol glycoside extracted from ginseng. It shows potent antioxidant and anticancer biological activities. It inhibited invasiveness to the basement membrane of endometrial cancer cell lines Ishikawa. Uses: Ginsenoside rb2 is extracted from ginseng and could inhibit the tumor growth and metastasis by destructing the angiogenesis. Group: Pharmaceutical. CAS No. 11021-13-9. Pack Sizes: 20 mg. Product ID: NP6993. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside-Rb3 | Ginsenoside Rb3 is a natural triterpenoid saponin. It has various pharmacological effects. It possesses the effect against isoproterenol-induced myocardial injury and heart function impairment, and that the mechanism of pharmacological action was related to the antioxidant activity of ginsenosideRb3 at least in part. It could markedly protected OGD-Rep induced ischemic injury and the mechanisms maybe related to its suppression of the intracellular Ca2+ elevation and inhibition of apoptosis and caspase activity. It could be a promising candidate in the development of a novel class of anti-ischemic agent. Uses: Ginsenoside rb3 inhibits the upregulation of phospho-iκb-α and nuclear translocation of nf-κb subunit p65 induced by glucose deprivation then reperfusion. Group: Pharmaceutical. CAS No. 68406-26-8. Pack Sizes: 20 mg. Product ID: NP7002. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rc | Ginsenoside Rc is a steroid glycoside, which is found exclusively in the plant genus Panax (ginseng). It has properties that inhibit or prevent tumors growth. It may have effects that prevent or limit the development of breast cancer. Uses: Ginsenoside rc is extracted from ginseng and has been found to be antioxidative, anti-aging and have sorts of other properties. Group: Pharmaceutical. CAS No. 11021-14-0. Pack Sizes: 20 mg. Product ID: NP6996. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rd | Ginsenoside Rd is a natural triterpenoid compound found in the roots of Panax ginseng C. A. Mey. Ginsenoside Re shows antioxidant activities. By preventing oxygen free radicals from attacking the cell membranes, Ginsenoside-Rd exhibites oxygen-glucose dep. Uses: Antioxidant. Group: Pharmaceutical. CAS No. 52705-93-8. Pack Sizes: 20 mg. Product ID: NP6989. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rd2 | Ginsenoside Rd2 is a composition of roots of Panax ginseng. Ginsenoside Rd is a primary constituent of the ginseng rhizome and the administration of ginsenoside Rd significantly increased the reduced GSHPx and glutathione reductase activity. Group: Pharmaceutical. CAS No. 83480-64-2. Pack Sizes: 10 mg. Product ID: B0005-479871. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Re | Ginsenoside Re is a natural triterpenoid compound found in the roots of Panax ginseng C. A. Mey. Ginsenoside Re shows effective antidiabetic activities via significant antioxidant efficacy, particularly in the prevention of diabetic microvasculopathy. Group: Pharmaceutical. CAS No. 52286-59-6. Pack Sizes: 50 mg. Product ID: NP6988. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rf | Ginsenoside Rf, extracted from the traditional Chinese herb ginseng, is a novel natural anticancer products known for its favorable safety and efficacy profiles. It inhibits Ca2+ channels in mammalian sensory neurons through a mechanism requiring G-proteins, whereas a variety of other ginsenosides were relatively ineffective. It might be useful in itself or as a template for designing additional modulators of neuronal Ca2+ channels. It induces G2/M phase cell cycle arrest and apoptosis in human osteosarcoma MG-63 cells through the mitochondrial pathway. Uses: Anti-arthritic agent. Group: Pharmaceutical. CAS No. 52286-58-5. Pack Sizes: 20 mg. Product ID: B0005-465147. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rg1 | Ginsenoside Rg1 is a natural triterpenoid isolated from the roots of Panax ginseng C. A. Mey. Ginsenoside Rg1 protects against arthitis through osteoclast differentiation inhibition. Ginsenoside Rg1 exhibits anti-inflammatory and anticancer activities. Ginsenoside Rg1 can be used in health products. Uses: Anti-inflammatory, anticancer. Group: Pharmaceutical. CAS No. 22427-39-0. Pack Sizes: 50 mg. Product ID: NP6987. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rg2 | Ginsenoside Rg2, a steroid glycosides, is abundant in Panax ginseng root, which has been used for prevention of illness. It has a neuroprotective effect against glutamate-induced neurotoxicity through mechanisms related to anti-oxidation and anti-apoptosis. It inhibits nicotinic acetylcholine receptor-mediated Na+ influx and channel activity. It might regulate the 5-HT3A receptors that are expressed in Xenopus oocytes. It may have properties that inhibit or prevent the growth of tumors. Ginsenoside Rg2 can be used in health products. Uses: Anti-arthritic agent. Group: Pharmaceutical. CAS No. 52286-74-5. Pack Sizes: 100 mg. Product ID: B1370-003062. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rh3 | Ginsenoside Rh3 is isolated from red ginseng and metabolized from ginsenoside Rg5. It can be anti-inflammatory. Uses: Ginsenoside rh3 is isolated from red ginseng and could be used as an anti-inflammatory agent. Group: Pharmaceutical. CAS No. 105558-26-7. Pack Sizes: 20 mg. Product ID: B0005-465144. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rh4 | Ginsenoside Rh4 is a saponin isolated from the roots of Panax notoginseng (Burk.) F. H. Chen. Ginsenoside Rh4 inhibits Wnt/β-Catenin, JAK2/STAT3, TGF-β/Smad2/3 and other signaling pathways. It is used as an adjuvant with low or non-haemolytic effect. Uses: Antitumour. Group: Pharmaceutical. CAS No. 174721-08-5. Pack Sizes: 5 mg. Product ID: B1370-003067. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rh7 | Ginsenoside Rh7 is a new dammarane-type triterpene saponins from the Leaves of Panax ginseng. Panax ginseng is an ancient and famous herbal drug in traditional chinese medicines. Bioactive saponins from natural medicines, a number of dammarane-type triterpene oligoglycosides were found to have anti-cancer, anti-arrhythmia and inhibitory effects on reducing sideeffects of steroid hormones. Group: Pharmaceutical. CAS No. 343780-68-7. Pack Sizes: 10 mg. Product ID: B0005-479859. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rh8 | Ginsenoside Rh8 is a saponin composition of roots of Panax ginseng. Ginsenoside-Rh8 was also obtained as a white powder. Ginsenosides are the primary bioactive components of Asian ginseng and more than 30 ginsenosides were reported from ginseng so far. Ginsenosides Rbl, Rb2, Rc, Rd, Rgl, Rg2, and Re are major constituents of white and red ginsengs, while ginsenosides Rg3, Rgs, and Rg6 are known to be unique constituents of red ginseng. Group: Pharmaceutical. CAS No. 343780-69-8. Pack Sizes: 5 mg. Product ID: B0005-479860. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rk2 | Ginsenoside Rk2 is a new dammarane glycosides isolated from the processed ginseng. Ginseng (Panax ginseng C. A. Meyer, Araliaceae) is one of the most popular herbal medicines in the Orient. The most well known chemical constituent of ginseng is ginsenoside, which is a dammarane glycoside. More than 30 ginsenosides were reported from ginseng so far. Group: Pharmaceutical. CAS No. 364779-14-6. Pack Sizes: 10 mg. Product ID: B0005-479862. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Rk3 | Ginsenoside Rk3 is reportedly present in the processed Radix notoginseng that is often used as a major ingredient of the compound preparation for ischemic heart diseases. Ginsenoside Rk3 and Rh4could have a role in treating inflammatory diseases. Uses: Anti-inflammatory/anti-tumor. Group: Pharmaceutical. CAS No. 364779-15-7. Pack Sizes: 10 mg. Product ID: NP7057. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ginsenoside Ro | Ginsenoside Ro, the predominant ginsenoside in the rhizome, showes inhibitory activity against 5αR. It demonstrates significant anti-thrombic, anti-inflammatory, and anti-hepatitis activities in experimental models. It shows no hemolytic nor cytotoxic activities. Uses: Anti-infllammtory, anti-hepatitic activities, and showed inhibitory activity. Group: Pharmaceutical. CAS No. 34367-04-9. Pack Sizes: 20 mg. Product ID: NP7017. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GIP (human) | GIP (human) is a potent insulinotropic hormone synthesized by duodenal K-cells. It inhibits gastric acid secretion and stimulates pancreatic insulin release in response to glucose. Group: Pharmaceutical. CAS No. 100040-31-1. Pack Sizes: 1 mg. Product ID: BAT-006165. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GIT 27 | GIT 27 is an orally active immunomodulatory agent. It inhibits TNF-α secretion via interference of macrophage TLR4 and TLR 2/6 signaling pathway. Group: Pharmaceutical. CAS No. 6501-72-0. Pack Sizes: 50 mg. Product ID: B0084-272123. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Givosiran sodium | Givosiran sodium is a small interfering RNA (siRNA) directed towards delta-aminolevulinate synthase 1 (ALAS1). Givosiran sodium has been indicated for the treatment of adults with acute hepatic porphyria (AHP). Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-212888. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabralide A | Glabralide A is a kind of a unique skeleton of the chalcone-coupled monoterpenoid. It has a bicyclo [2.2.2] octene core unit with five chiral centers. Group: Pharmaceutical. CAS No. 1969289-10-8. Pack Sizes: 1 mg. Product ID: NP0970. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabralide B | Glabralide B is an enchanting natural compound, manifesting an impeccable amalgamation of anti-inflammatory and antioxidant effects. Group: Pharmaceutical. CAS No. 2170388-84-6. Pack Sizes: 1 mg. Product ID: NP4981. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabralide C | Glabralide C, an organic compound derived from the Astragalus glabrescens blossoms, has been shown to exhibit neuroprotection and could be a promising treatment for neurodegenerative disorders like Alzheimer's. Group: Pharmaceutical. CAS No. 2170388-85-7. Pack Sizes: 1 mg. Product ID: NP5034. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabranin | Glabranin is a natural flavonoid isolated from the roots of Glycyrrhiza uralensis Fisch. Group: Pharmaceutical. CAS No. 41983-91-9. Pack Sizes: 1 mg. Product ID: NP2138. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabratine | Glabratine is a glucoalkaloid isolated from Uncaria glabrata. Group: Pharmaceutical. CAS No. 142750-47-8. Pack Sizes: 1 mg. Product ID: NP0687. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabredelphinine | Glabredelphinine, a naturally occurring substance, has garnered attention for its remarkable efficacy in inducing apoptosis in tumors, thus displaying its potent anti-tumor activity. Furthermore, it has exhibited potential therapeutic benefits in the treatment of Alzheimer's disease by impeding acetylcholinesterase activity. Through its multifaceted mechanisms, Glabredelphinine represents an intriguing candidate for further exploration within both oncological and neurological research domains. Group: Pharmaceutical. CAS No. 132160-37-3. Pack Sizes: 1 mg. Product ID: NP0658. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glabrol | Glabrol is a flavonoid showing inhibition of PTP1B and CYP1B1. Group: Pharmaceutical. CAS No. 59870-65-4. Pack Sizes: 10 mg. Product ID: B2703-218794. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glasdegib | Glasdegib is an orally bioavailable small-molecule inhibitor of the Hedgehog (Hh) signaling pathway that binds to Smoothened (Smo) and inhibits signal transduction. It has been shown to attenuate leukemia stem cell self-renewal and cell cycle progression in primary acute myeloid leukemia cells and in an in vivo Drosophila model. Group: Pharmaceutical. CAS No. 1095173-27-5. Pack Sizes: 50 mg. Product ID: B0084-462711. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glatiramer acetate | Glatiramer acetate is an immunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found in myelin basic protein, namely L-glutamic acid, L-lysine, L-alanine, and L-tyrosine. Uses: multiple sclerosis (ms) is a chronic autoimmune illness that affects the central nervous system. glatiramer acetate is one medicine used to treat ms. glatiramer acetate is primarily used to treat multiple sclerosis (ms), but because of its immunomodulatory qualities and capacity to control inflammatory reactions, scientists have also looked at the possibility of using it in the drug discovery p. Group: Pharmaceutical. CAS No. 147245-92-9. Pack Sizes: 50 mg. Product ID: BAT-014243. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glaucocalyxin A | Glaucocalyxin A, which is extracted from the herbs of Rabdosia rubescens, inhibited Akt phosphorylation, suppressed proliferation, and promoted apoptosis in a dose-dependent manner, but not in normal glial cells. Glaucocalyxin A activated caspase-3, decreased BAD phosphorylation, and reduced the expression of X-linked inhibitor of apoptosis protein. Glaucocalyxin A inhibited collagen-stimulated tyrosine phosphorylation of Syk, LAT, and phospholipase Cγ2, the signaling events in collagen receptor GP? pathway. Uses: Antiplatelet/antithrombotic. Group: Pharmaceutical. CAS No. 79498-31-0. Pack Sizes: 10 mg. Product ID: NP1506. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glaucocalyxin B | Glaucocalyxin B is a diterpenoid isolated from Rabdosia japonica with anti-inflammatory effects. Group: Pharmaceutical. CAS No. 80508-81-2. Pack Sizes: 5 mg. Product ID: B2703-334427. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gliclazide Impurities | Gliclazide Impurities hold paramount importance within the pharmaceutical sector, serving as critical markers for characterizing and verifying the purity of gliclazide, utilized in managing type 2 diabetes. Rigorous monitoring of these impurities underpins quality control and safety evaluations, ensuring therapeutic efficacy and mitigating potential adverse effects for diabetic patients. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gliclazide Impurity B | Gliclazide Impurity B is used in the preparation of various ureas and other pharmaceutical compounds. Group: Pharmaceutical. CAS No. 54786-86-6. Pack Sizes: 100 mg. Product ID: B1370-440025. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glimepiride | Glimepiride is a medium to long-acting sulfonylurea antidiabetic drug. It acts by stimulating the insulin release from pancreatic β-cells and decreases glucose output from the liver. Group: Pharmaceutical. CAS No. 93479-97-1. Pack Sizes: 10 g. Product ID: NP3448. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glimepiride Impurities | Glimepiride Impurities play a crucial role in the pharmaceutical industry, primarily in the quality control and development of glimepiride-based medications. They are used to evaluate and ensure the purity and efficacy of glimepiride, a medication widely used in the treatment of type 2 diabetes by enhancing insulin secretion from pancreatic beta cells. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glimepiride Impurity A | Glimepiride Impurity A is the cis-isomer of Glimepiride found in a bulk drug substance. Glimepiride is an antidiabetic medication used to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 684286-46-2. Pack Sizes: 25 mg. Product ID: B2694-261627. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glimepiride Impurity I | An impurity of Glimepiride, an antidiabetic medication used to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 878480-70-7. Pack Sizes: 5 mg. Product ID: B2694-472087. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glipizide | Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. Glipizide is used to treat high blood sugar levels caused by a type of diabetes mellitus called type 2 diabetes. Uses: Hypoglycemic agents. Group: Pharmaceutical. CAS No. 29094-61-9. Pack Sizes: 50 g. Product ID: B2692-089502. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glipizide Impurities | Glipizide Impurities are critical in the biomedical industry for analytical and quality control purposes in antidiabetic formulations. These impurities are employed to ensure the purity, efficacy, and safety of Glipizide, a well-known medication used in managing Type 2 diabetes by enhancing insulin secretion from pancreatic beta cells. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| [Gln4]-Neurotensin | Neurotensin induces contractions in smooth muscle cells, playing a role in regulating digestive activity in vitro and in vivo. Group: Pharmaceutical. CAS No. 61445-54-3. Pack Sizes: 5 mg. Product ID: BAT-006176. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Globularin | Globularin is a natural iridoid isolated from the herb of Globularia alypum. Group: Pharmaceutical. CAS No. 1399-49-1. Pack Sizes: 1 mg. Product ID: NP3852. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glomeratose A | Glomeratose A is a phenylpropanoid isolated from Polygala tenuifolia. Group: Pharmaceutical. CAS No. 202471-84-9. Pack Sizes: 5 mg. Product ID: B2703-334564. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GLP-1(7-36) amide | GLP-1(7-36) amide is a glucose-dependent insulinotropic peptide displaying high affinity for GLP-1 receptors expressed in rat insulinoma-derived RINm5F cells (Kd = 204 pM). GLP-1 (7-36) amide exhibits antiapoptotic effects in hippocampal neurons and reduces food intake in fasted rats following central administration. Group: Pharmaceutical. CAS No. 107444-51-9. Pack Sizes: 1 mg. Product ID: BAT-006200. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GLP-1(7-37) | GLP-1 (7-37) is an insulinotropic peptide generated from the precursor peptide GLP-1 (1-37). It is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M and has no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. It participates in the physiological regulation of insulin secretion. Uses: Glp-1 (7-37) acetate participates in the physiological regulation of insulin secretion. Group: Pharmaceutical. CAS No. 106612-94-6. Pack Sizes: 1 mg. Product ID: BAT-006116. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GLP-1 TFA | GLP-1 is a potent insulin secretagogue that has multiple synergetic effects on the glucose-dependent insulin secretion pathways of the beta-cell. Group: Pharmaceutical. Pack Sizes: 25 mg. Product ID: BAT-016125. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GLPG-0187 | GLPG-0187 is a small molecule integrin receptor antagonist (IRA) with nanomolar affinity for the RGD-integrin receptors αvβ1, αvβ3, αvβ5, αvβ6 and α5β1 (IC50s = 1.2-3.7 nM). Integrin receptors are expressed on the surface of tumor vessel endothelial cells and some types of cancer cells, and play a crucial role in endothelial cell adhesion and migration. This compound shows an inhibitory activity of angiogenesis, bone-resorption and tumor, which is hopefully used as an anticancer drug. Uses: An integrin receptor antagonist (ira) can be used as an anticancer drug. Group: Pharmaceutical. CAS No. 1320346-97-1. Pack Sizes: 10 mg. Product ID: B0084-484680. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GLPG-1690 | GLPG-1690, an imidazopyridine derivative, has been found to be a selective autotaxin inhibitor that could probably be effective as an anti-inflammatory agent and is under Phase II trial against Idiopathic pulmonary fibrosis (IPF). Group: Pharmaceutical. CAS No. 1628260-79-6. Pack Sizes: 200 mg. Product ID: B0084-475919. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucagon-like peptide 1 (1-37), human | Glucagon-like peptide 1 (1-37) is a pancreatic hormone synthesized by post-translational processing of proglucagon. It decreases plasma glucose level in high-fat-fed mice when administered at 25 nmol/kg. Glucagon-like peptide 1 (1-37) exhibits no effect on food intake in rats and does not enhance pancreatic insulin secretion. However it induces insulin expression in intestinal epithelial cells, which can restore glucose homeostasis when implanted into diabetic mice. Group: Pharmaceutical. CAS No. 87805-34-3. Pack Sizes: 5 mg. Product ID: BAT-010492. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucagon (swine) | Glucagon, a peptide compound, is effective in increasing the glucose concentration in bloodstream and could be released by pancreatic α cells. Group: Pharmaceutical. CAS No. 16941-32-5. Pack Sizes: 10 mg. Product ID: BAT-010767. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucamine Impurities | Glucamine impurities are utilized in the biomedical sector as reference standards in evaluating and ensuring the purity of glucamine-based pharmaceuticals and diagnostic agents. Their analysis and identification are crucial in understanding drug efficacy, stability, and safety, particularly in the treatment of glaucoma and cancer through glucamine derivatives. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucodigifucoside | Glucodigifucoside is a compound of the steroidal saponins. Group: Pharmaceutical. CAS No. 2446-63-1. Pack Sizes: 5 mg. Product ID: B0005-053625. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucosamine Impurities | Glucosamine Impurities occupy a fundamental role in the domain of pharmaceutical quality assurance, particularly for glucosamine-based drugs. They facilitate the identification and assessment of potential contaminants or degradation byproducts, thereby safeguarding the therapeutic integrity and efficacy of formulations used in treating osteoarthritis and associated joint ailments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucosylisomaltol | Glucosylisomaltol is an indicator for browning reaction. Group: Pharmaceutical. CAS No. 85559-61-1. Pack Sizes: 25 mg. Product ID: B2699-485024. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glucovanillin | Glucovanillin, a phenolic compound of natural origin, has emerged as a promising antioxidant and anti-inflammatory agent. Remarkably, it exhibits therapeutic potential in the management of neurodegenerative conditions, such as Alzheimer's and Parkinson's disease. Further, glucovanillin has also garnered attention for its antihypertensive effects and its potential use in the treatment of cardiovascular disease. The versatility of glucovanillin warrants further exploration in the scientific community. Group: Pharmaceutical. CAS No. 494-08-6. Pack Sizes: 100 mg. Product ID: B1999-093052. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutamine Impurities | Glutamine Impurities play a pivotal role in biomedical research, particularly in assessing the purity and efficacy of glutamine formulations. These impurities are critical in understanding the therapeutic impact and safety profile of drugs targeting inflammatory diseases and metabolic disorders, ensuring high standards in pharmaceutical development and quality control. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathione | Glutathione (GSH) is an endogenous antioxidant that plays a major role in reducing reactive oxygen species formed during cellular metabolism and the respiratory burst. Glutathione may decrease the concentrations of inflammatory cytokines (IL-6, IL-18), and neutrophils in lung tissue, increase the level of serum Ca2+, and be useful for the treatment of ANP. Glutathione can be used not only as medicine but also as a base material for functional foods. It is widely used in functional foods for delaying aging, enhancing immunity, and anti-tumor. Glutathione is the main ingredient in ''whitening needle'' injections, and it is also the main ingredient in many beauty products on the market. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 70-18-8. Pack Sizes: 100 g. Product ID: BAT-010793. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathione EP Impurity C | Oxiglutatione is a stabilized formulation of disodium glutathione disulfide (GSSG; oxidized glutathione) and cisplatin (1000:1) with potential chemoprotective and immunomodulating activities. Mimicking endogenous GSSG, Oxiglutatione acts as a competitive substrate for gamma-glutamyl-transpeptidase (GGT), which may result in the S-glutathionylation of proteins, predominantly actin, a redox stress on endoplasmic reticulum (ER), and ER stress-induced apoptosis. S-glutathionylation may be stimulated by reactive oxygen species (ROS) liberated by an oxiglutatione-induced increase in GGT activity. Oxiglutatione may also induce phosphorylation of proteins such as ERK and p38, two kinases that play critical regulatory roles in cell proliferation and apoptosis. The cisplatin component of this agent does not provide an effective therapeutic concentration of cisplatin in vivo. Group: Pharmaceutical. CAS No. 27025-41-8. Pack Sizes: 25 g. Product ID: B0084-064728. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathione EP Impurity D | Glutathione EP Impurity D is a substrate used for the biosynthesis of L-glutathione by glutathione synthetase. It is used to study the active sites and kinetics of glutathione synthestase(s). It is also used in biological studies for the detection of thiols. Group: Pharmaceutical. CAS No. 636-58-8. Pack Sizes: 1 g. Product ID: BAT-015930. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathione Impurities | Glutathione Impurities, integral to biomedical endeavors, serve as reference standards in quality control during drug formulation and production. Their pivotal role ensures therapeutic agents' purity and safety against oxidative stress-related ailments, such as Parkinson's and Alzheimer's, while also fostering progress in detoxification science and antioxidant intervention strategies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathionesulfonic acid | Glutathionesulfonic acid is a metabolite of glutathione. Group: Pharmaceutical. CAS No. 3773-7-7. Pack Sizes: 100 mg. Product ID: BAT-010743. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutaurine | Glutaurine is an endogenous hormone found in the parathyroid and mammalian brain. This compound mimicks the anxiolytic drug diazepam, and has been identified as an antiepileptic. Group: Pharmaceutical. CAS No. 56488-60-9. Pack Sizes: 10 mg. Product ID: BAT-014264. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gly3-VC-PAB-MMAE | Gly3-VC-PAB-MMAE is a drug-linker conjugate for ADC consisting of a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Group: Pharmaceutical. CAS No. 2684216-48-4. Pack Sizes: 2 mg. Product ID: BADC-01340. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glyburide Impurities | Glyburide Impurities, as chemical derivatives stemming from glyburide synthesis, hold substantial value in the realm of pharmaceutical analysis. Their examination is essential for evaluating the safety and effectiveness of glyburide, influencing drug stability and clinical performance in type 2 diabetes management, thereby navigating towards superior therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glycerol Impurities | Glycerol Impurities are critical in analyzing and ensuring the purity of pharmaceutical-grade glycerol, which is essential for producing various drugs, such as those for hypertension and angina. These impurities can influence the efficacy and safety of medication, prompting rigorous examination in drug formulation development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glycerol monostearate | Glycerol monostearate can be used as an emulsifier, an anti-caking and thickening agent. Group: Pharmaceutical. CAS No. 31566-31-1. Pack Sizes: 500 g. Product ID: B1370-090022. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glycerophosphate Impurities | Glycerophosphate Impurities, typically encountered in biomedical formulations, are scrutinized for their impact on drug efficacy and safety. These impurities can affect the stability and activity of phospholipid-based drugs and are crucial in studies related to bone disease treatments and metabolic disorders, ensuring purified formulations for therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glycidyl acrylate | Glycidyl acrylate. Group: Pharmaceutical. CAS No. 106-90-1. Pack Sizes: 10 g. Product ID: BB076981. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glycine Bisphosphonate | Glycine Bisphosphonate is a possible inhibitor of the plant vacuolar proton-pumping pyrophosphatase. Group: Pharmaceutical. CAS No. 41003-10-5. Pack Sizes: 25 mg. Product ID: B1030-472135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.